Microfocused Ultrasound for Facial Pigmentary Diseases and Rosacea
NCT: NCT07667972 · ACTIVE_NOT_RECRUITING
Brief Summary
This clinical study will evaluate the efficacy and safety of microfocused ultrasound treatment in patients with facial pigmentary diseases and rosacea. The study includes two independent disease cohorts: a facial pigmentary disease cohort and a rosacea cohort. Participants in each cohort will be randomly assigned to receive either active microfocused ultrasound treatment or sham stimulation. Sham stimulation will follow the same treatment procedure as active treatment but will not deliver effective therapeutic ultrasound energy. Participants will receive one treatment session per month for 6 months and will be followed for up to 12 months. The study will assess changes in clinical severity scores, digital skin imaging parameters, patient-reported symptoms, quality of life, and safety outcomes, including adverse events.
Frequently Asked Questions
What is Microfocused Ultrasound for Facial Pigmentary Diseases and Rosacea?
Microfocused Ultrasound for Facial Pigmentary Diseases and Rosacea is a clinical trial registered under NCT07667972. Current status: ACTIVE_NOT_RECRUITING.
What is the status of NCT07667972?
The current status of NCT07667972 (Microfocused Ultrasound for Facial Pigmentary Diseases and Rosacea) is: ACTIVE_NOT_RECRUITING.
When did Microfocused Ultrasound for Facial Pigmentary Diseases and Rosacea start?
Microfocused Ultrasound for Facial Pigmentary Diseases and Rosacea started on 2025-10-01.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.